… research projects devoted to finding new treatments for dyskinesia, and improving the delivery of levodopa into the … supported a D1 agonist as a potential therapy for dyskinesia. Dyskinesia is still a major adverse effect of levodopa for …

… models of Parkinson's disease and L-DOPA-induced dyskinesia. Morari is known for his studies of basal ganglia function in parkinsonism and dyskinesia, where he combined two experimental approaches, …

… started . Learn more about PPMI . Treating Complications : Dyskinesia is uncontrolled, involuntary movement that may … to test a medication, dipraglurant, as a treatment for dyskinesia in Parkinson’s disease. The Michael J. Fox … trial is recruiting 140 participants with Parkinson’s and dyskinesia at sites across the United States. The trial will …

… address both motor symptoms, as well as L-dopa-induced dyskinesias. The team, with previous MJFF funding, has … or prevent the motor symptoms of PD, and L-dopa-induced dyskinesias. This treatment provides a scalable autologous … the motor symptoms of Parkinson's and L-dopa-induced dyskinesias. It could provide a scalable cell replacement …

… trials testing a novel treatment for levodopa-induced dyskinesias. His work focuses on preclinical models to test novel pharmacological treatments for levodopa-induced dyskinesias, a major side effect of Parkinson’s disease (PD) …

… called glutamate, which when perturbed is thought to cause dyskinesias, was also inhibited through by this drug. In … for Parkinson’s patients, while at the same time reducing dyskinesias. But today’s results, culled from three … if A2A antagonists might work to prevent, or lessen, dyskinesias.  And certain research focusing on the positive …